Mississippi 2025 Regular Session

Mississippi House Bill HB40

Introduced
1/10/25  
Refer
1/10/25  

Caption

Health insurance; require coverage of medically necessary treatment of mental health and substance use disorders.

Summary

House Bill 40 would require most Mississippi health insurance policies that cover hospital, medical, or surgical services to cover medically necessary treatment for mental health and substance use disorders for policies issued, amended, or renewed on or after January 1, 2026. The bill defines key terms such as “generally accepted standards of mental health and substance use disorder care,” “medically necessary treatment,” and “utilization review,” and it directs insurers to use current evidence-based clinical standards and specialty association guidelines when making medical necessity and level-of-care decisions. It also bars insurers from limiting coverage for chronic or pervasive behavioral health conditions to short-term or acute treatment only, and requires coverage to continue when in-network care is unavailable by arranging out-of-network services at in-network cost-sharing levels. The bill further prohibits insurers from denying medically necessary services on the theory that they should be covered by a public entitlement program such as Medicaid, Medicare, SSI, SSDI, or special education/IEPs. It also voids contract provisions that reserve discretionary authority to insurers in ways that conflict with Mississippi law, and authorizes the Commissioner of Insurance to impose civil penalties for violations. In addition, the bill amends existing Mississippi insurance statutes on alcoholism and mental illness coverage so they conform to the new behavioral health coverage rules, with the new provisions controlling in the event of a conflict. HB40 would significantly affect state insurance regulation by expanding and standardizing behavioral health parity requirements across many health plans and alternative delivery systems. It would require insurers and their utilization review contractors to rely on current clinical standards, provide education and transparency around review criteria, conduct interrater reliability testing, and follow Mississippi prior authorization and utilization review rules. The bill also preserves and updates older Mississippi mental illness and alcoholism coverage statutes, but makes clear that the new requirements supersede conflicting older limits or procedures for plans subject to the act. The general sentiment reflected in the bill text is strongly supportive of broader access to mental health and substance use disorder treatment and of limiting insurer discretion in coverage decisions. Because there were no committee transcripts or recorded votes provided, there is no documented debate history to indicate formal support or opposition in committee or on the floor. Based on the structure of the bill, its policy direction appears aimed at strengthening parity, improving access to care, and reducing denials tied to insurer-specific review standards. The main points of contention likely concern the bill’s impact on insurer flexibility, utilization management, and costs. Insurers may object to the requirement that they follow external clinical guidelines, the prohibition on more restrictive internal criteria, the mandate to authorize the next higher level of care if the preferred level is unavailable, and the ban on discretionary clauses. Providers and patient advocates would likely support those provisions as protections against denials and under-treatment, while insurers may view them as limiting plan design and increasing administrative and claims costs.

Impact

HB40 would amend Mississippi insurance law to require behavioral health coverage for medically necessary mental health and substance use disorder treatment in most hospital, medical, and surgical policies beginning with policies issued, amended, or renewed on or after January 1, 2026. It would also revise existing statutes governing alcoholism and mental illness coverage, and it would make the new standards controlling where they conflict with older law. The bill expands the Commissioner of Insurance’s enforcement authority by allowing civil penalties for violations and by invalidating conflicting policy or provider-agreement terms, including discretionary clauses that could affect judicial review of benefit denials.

Sentiment

The bill’s overall tone is pro-coverage and pro-parity, with a clear policy preference for expanding access to mental health and substance use disorder treatment and constraining insurer denials. No committee discussion or vote record was provided, so there is no direct evidence of legislative debate or recorded support/opposition. On its face, the bill appears designed to address perceived gaps in behavioral health coverage and to align insurer practices with current clinical standards.

Contention

The likely areas of contention are insurer discretion, utilization review standards, and cost exposure. Insurers may oppose the requirement to use external clinical guidelines, the prohibition on more restrictive internal criteria, the mandate to cover out-of-network care when in-network services are unavailable, and the voiding of discretionary clauses. Supporters such as behavioral health advocates, patients, and providers would likely favor these provisions because they reduce denials, improve access to care, and limit insurer reliance on narrow or inconsistent review practices.

Companion Bills

No companion bills found.

Previously Filed As

MS HB1

Economic development; provide incentives for certain economic development projects.

MS SB2001

Economic development; provide incentives for certain economic development projects.

MS SB2001

Project Poppy Fund; create.

MS HB1

Project Atlas Fund; create.

MS HB2

Appropriation; additional to MDA for certain projects.

MS SB2002

Appropriation; additional to MDA for certain projects.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.